IRIS
ARPINO, GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 479
AS - Asia 393
NA - Nord America 301
SA - Sud America 37
AF - Africa 16
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 279
IT - Italia 152
CN - Cina 147
DE - Germania 100
IN - India 99
IE - Irlanda 63
GB - Regno Unito 35
FR - Francia 27
VN - Vietnam 17
ID - Indonesia 15
CA - Canada 14
JP - Giappone 14
RU - Federazione Russa 14
IQ - Iraq 12
ES - Italia 11
KR - Corea 11
PE - Perù 11
TR - Turchia 11
NL - Olanda 10
PH - Filippine 10
TW - Taiwan 10
SG - Singapore 9
BR - Brasile 8
CZ - Repubblica Ceca 8
RO - Romania 8
MK - Macedonia 7
AR - Argentina 6
CH - Svizzera 6
HK - Hong Kong 6
PL - Polonia 6
AU - Australia 5
BD - Bangladesh 5
CI - Costa d'Avorio 5
CO - Colombia 5
MX - Messico 5
PT - Portogallo 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
UA - Ucraina 4
VE - Venezuela 4
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
IL - Israele 3
SE - Svezia 3
TH - Thailandia 3
AP - ???statistics.table.value.countryCode.AP??? 2
AT - Austria 2
BB - Barbados 2
BG - Bulgaria 2
EC - Ecuador 2
EU - Europa 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
QA - Qatar 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CU - Cuba 1
FI - Finlandia 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 1.237
Salva come PNG Salva come JPEG
Città #
Dublin 58
Beijing 51
Mountain View 32
Shanghai 20
Wuhan 19
Duncan 17
Naples 17
Dong Ket 16
Mumbai 16
Hangzhou 14
Houston 14
Ashburn 13
University Park 13
Napoli 12
Woodbridge 12
Duhok 10
Hyderabad 9
Ann Arbor 8
Jakarta 8
Milan 8
Bengaluru 7
Boardman 7
Chennai 7
Kansas City 7
Salford 7
Wilmington 7
Cornelius 6
Guangzhou 6
London 6
Nutley 6
Rome 6
San Jose 6
Seoul 6
Singapore 6
Taipei 6
Buenos Aires 5
Dearborn 5
Ottawa 5
Amsterdam 4
Cankaya 4
Encino 4
Lima 4
New Delhi 4
Warsaw 4
Berlin 3
Bologna 3
Central District 3
Charleston 3
Chicago 3
Davao City 3
Genoa 3
Gurgaon 3
Madrid 3
Moscow 3
Nürnberg 3
Pekanbaru 3
Riva 3
Seattle 3
Tbilisi 3
Torino 3
Trujillo 3
Zhengzhou 3
Atascadero 2
Bangalore 2
Bangkok 2
Barcelona 2
Bari 2
Boston 2
Brussels 2
Calviá 2
Cambridge 2
Central 2
Changsha 2
City of Saint Peters 2
Collegeville 2
Coral Gables 2
Corsico 2
Dallas 2
Delhi 2
Dhaka 2
Dijon 2
Doha 2
Durban 2
Fairfield 2
Ferrara 2
Formia 2
Freising 2
Fremont 2
Genova 2
Goran 2
Irving 2
Lake Forest 2
Lisbon 2
Mason 2
Memphis 2
Milpitas 2
Nanchang 2
Palermo 2
Philadelphia 2
Pignone 2
Totale 632
Salva come PNG Salva come JPEG
Nome #
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives, file e268a72d-e224-4c8f-e053-1705fe0a812c 626
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance., file e268a72c-c3ab-4c8f-e053-1705fe0a812c 91
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial, file e268a733-8ef9-4c8f-e053-1705fe0a812c 84
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy, file e268a72d-09b5-4c8f-e053-1705fe0a812c 71
Features of aggressive breast cancer, file e268a72d-09b9-4c8f-e053-1705fe0a812c 68
Neoadjuvant treatment of HER2 and hormone-receptor positive breast cancer - Moving beyond pathological complete response., file e268a72d-1ffe-4c8f-e053-1705fe0a812c 60
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study, file e268a72d-0f93-4c8f-e053-1705fe0a812c 59
First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial, file 3851a6a8-a6c6-4c76-b264-a3daecec5dcb 41
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study, file e268a72d-09b3-4c8f-e053-1705fe0a812c 40
Overcoming treatment resistance in HER2-positive breast cancer: potential strategies., file e268a72d-1fff-4c8f-e053-1705fe0a812c 30
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study, file e268a72f-b2fb-4c8f-e053-1705fe0a812c 27
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature, file e268a72f-b44e-4c8f-e053-1705fe0a812c 22
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients, file e268a733-67f7-4c8f-e053-1705fe0a812c 16
Home Exercise Program is an effective tool in improving upper limb function and quality of life in breast cancer survivors: A retrospective observational study, file e268a730-1125-4c8f-e053-1705fe0a812c 13
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy., file e268a72d-1a21-4c8f-e053-1705fe0a812c 12
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI), file e268a732-bbae-4c8f-e053-1705fe0a812c 5
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial, file e268a732-d86c-4c8f-e053-1705fe0a812c 4
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study, file 96ab5c5f-978b-43eb-afff-a99f250c884b 3
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts., file e268a72d-1965-4c8f-e053-1705fe0a812c 3
Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction, file e268a731-41f3-4c8f-e053-1705fe0a812c 1
Perspective on circulating tumor cell clusters: Why it takes a village to metastasize, file e268a731-45cd-4c8f-e053-1705fe0a812c 1
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis, file e268a732-7d61-4c8f-e053-1705fe0a812c 1
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial, file e268a732-995c-4c8f-e053-1705fe0a812c 1
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?, file e268a732-dcd3-4c8f-e053-1705fe0a812c 1
Totale 1.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.575
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201951 0 0 0 0 0 0 0 0 0 14 17 20
2019/2020165 13 35 12 5 11 15 16 5 22 12 4 15
2020/2021135 6 9 14 17 23 10 12 6 6 10 10 12
2021/2022123 12 2 5 10 10 12 5 2 10 26 20 9
2022/2023151 4 7 4 7 6 13 14 13 17 21 28 17
2023/2024180 11 10 41 25 15 13 28 17 10 10 0 0
Totale 1.280